medigraphic.com
ISSN 0185-6014 (Print)
Órgano oficial de difusión de la Federación Mexicana de Patología Clínica, AC y de la Asociación Latinoamericana de Patología Clínica/Medicina de Laboratorio

2016, Number 4

<< Back Next >>

Rev Mex Patol Clin Med Lab 2016; 63 (4)

Cellular atypias associated with HPV and HIV, review of 40 cases

Sánchez-Hernández JA, Rivera-Tapia JA, Herrera-Castillo CK, Muñoz-Zurita G, Pérez TR

Language: Spanish
References: 12
Page: 176-178
PDF size: 264.30 Kb.


ABSTRACT

The immunodeficiency caused by chronic HIV infection increases the risk of acquiring human papillomavirus (HPV) and HPV infections. Forty HIV-positive patients confirmed by Western blot in the Hospital General del Sur Puebla, México, were explored; all of them underwent an exfoliative cytology (Papanicolaou), which was stained and processed at the Laboratory of Cell Biology of the School of Medicine of the Benemérita Universidad Autónoma de Puebla according to the technique of modified Papanicolaou stain. During the taking of the cervicovaginal exfoliative cytology, samples from the cervix were taken with a cytobrush for PCR. Of the 40 patients, 31 were positive for any serotype of HPV; 22 of them had some type of cellular atypia (70.9%), which shows a very high incidence of cellular atypia in patients suffering from HIV and HPV simultaneously.


REFERENCES

  1. Caraballo L, Salazar N, Lorenzo C, González-Blanco M, Carrillo C, Hernández D. Infección por virus de papiloma humano: asociación entre infección genital y anal-perianal. Rev Obstet Ginecol Venez. 2010; 70 (4): 254-264.

  2. Frisch M, Biggar RJ, Goedert JJ. Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J Natl Cancer Inst. 2000; 92 (18): 1500-1510.

  3. Soh J, Rositch AF, Koutsky L, Guthrie BL, Choi RY, Bosire RK et al. Individual and partner risk factors associated with abnormal cervical cytology among women in HIV-discordant relationships. Int J STD AIDS. 2014; 25 (5): 315-324.

  4. Houlihan CF, Larke NL, Watson-Jones D, Smith-McCune KK, Shiboski S, Gravitt PE et al. Human papillomavirus infection and increased risk of HIV acquisition. A systematic review and meta-analysis. AIDS. 2012; 26 (17): 2211-2222.

  5. Maglennon GA1, McIntosh PB, Doorbar J. Immunosuppression facilitates the reactivation of latent papillomavirus infections. J Virol. 2014; 88 (1): 710-716.

  6. Reigosa-Yániz AR. Sobre el virus del papiloma humano (VPH), su historia natural y diagnóstico. Salus. 2012; 16 (1): 3-4.

  7. Mbulawa ZZ, Johnson LF, Marais DJ, Coetzee D, Williamson AL. The impact of human immunodeficiency virus on human papillomavirus transmission in heterosexually active couples. J Infect. 2013; 67 (1): 51-58.

  8. Minkoff H, Zhong Y, Burk RD, Palefsky JM, Xue X, Watts DH et al. Influence of adherent and effective antiretroviral therapy use on human papillomavirus infection and squamous intraepithelial lesions in human immunodeficiency virus-positive women. J Infect Dis. 2010; 201 (5): 681-690.

  9. Veldhuijzen NJ, Snijders PJ, Reiss P, Meijer CJ, van de Wijgert JH. Factors affecting transmission of mucosal human papillomavirus. Lancet Infect Dis. 2010; 10 (12): 862-874.

  10. Ramírez JA, García AJ, Ramos G, Trujillo A, Blanco E. Hallazgos citopatológicos en cérvix de pacientes infectadas por virus de inmunodeficiencia humana. Rev Hosp Gral Quebrada 2003; 2 (1): 9-13.

  11. Auvert B, Lissouba P, Cutler E, Zarca K, Puren A, Taljaard D. Association of oncogenic and nononcogenic human papillomavirus with HIV incidence. J Acquir Immune Defic Syndr. 2010; 53 (1): 111-116.

  12. Grases PJ, Tresserra-Casas F, López-Marín L. Cuello uterino: atipias y lesiones premalignas no invasoras. Rev Obstet Ginecol Venez. 2006; 66 (2): 81-90.




2020     |     www.medigraphic.com